Condition: Non-Muscle Invasive Bladder Cancer · Sponsor: Merck Sharp & Dohme LLC
The goal of the study is to learn about the safety of Sacituzumab Tirumotecan and if people can tolerate it when given in the bladder and find the highest dose that people can take without having certain problems. Researchers will then choose a dose level of Sacituzumab Tirumotecan to use in future studies to learn how well the drug works.
This description comes directly from the study's public registry record.
Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
Always discuss trial participation with your own doctor first.
| Michael G Oefelein Clinical Trials ( Site 0053) | Bakersfield, California, United States | Recruiting |
| Moffitt Cancer Center ( Site 0057) | Tampa, Florida, United States | Recruiting |
| Northwestern University ( Site 0051) | Chicago, Illinois, United States | Recruiting |
| Johns Hopkins University ( Site 0055) | Baltimore, Maryland, United States | Recruiting |
| Princess Margaret Cancer Centre ( Site 0003) | Toronto, Ontario, Canada | Recruiting |
| Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Univer ( Site 0002) | Sherbrooke, Quebec, Canada | Recruiting |
| Hôpital Claude Huriez ( Site 0012) | Lille, Nord, France | Active Not Recruiting |
| HENRI MONDOR HOSPITAL ( Site 0011) | Créteil, Val-de-Marne, France | Active Not Recruiting |
| Gustave Roussy ( Site 0013) | Villejuif, Val-de-Marne, France | Active Not Recruiting |
| Erasmus Medisch Centrum ( Site 0032) | Rotterdam, South Holland, Netherlands | Recruiting |
| Hospital Universitario Virgen de la Victoria ( Site 0043) | Málaga, Andalusia, Spain | Recruiting |
| Hospital Universitario 12 de Octubre ( Site 0042) | Madrid, Spain | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06637423